‘Human Nature’ offers CRISPR novices a basic introduction


Subscribe Us

By subscription, you consent to allow Ubigene Biosciences to store and process the information provided above to deliver the latest news, research spotlight, and promotions. You can unsubscribe from these communications at anytime.

Location:Home > About Us > Blogs >

‘Human Nature’ offers CRISPR novices a basic introduction

Humans have been tinkering with the genes of plants and animals through selective breeding for millennia. But the ability to change our own DNA is something very new.

The gene-editing tool CRISPR offers the promise of correcting genetic typos that cause a range of diseases. The documentary Human Nature — which opened in select U.S. cities on March 13, with more to follow — introduces viewers to the technology. Graphics, archival footage and beautiful imagery help explain how scientists took a DNA-cutting enzyme and its guide molecule, which form the basis of bacterial immune systems, and transformed them into CRISPR/Cas9, often just called CRISPR. Pioneers of the technology, including Jennifer Doudna, Feng Zhang, George Church and Emmanuelle Charpentier, recount serendipitous discoveries and hard-won insights in the tale of CRISPR’s development over several decades.

At the heart of the film is an ethical discussion of whether to allow scientists to use CRISPR to make changes in eggs, sperm or embryos that could be inherited by future generations. In one scene, Russian President Vladimir Putin tells a group of young people that using CRISPR to make designer people could be more dangerous than the nuclear bomb. In a counterpoint, bioethicist Alta Charo of the University of Wisconsin Law School in Madison says such fears may be overblown.

The film is wide-ranging, but with a few glaring omissions. Most notably, in 2018, Chinese researcher Jiankui He announced that human babies had been born from CRISPR-edited embryos (SN: 12/22/18 & 1/5/19, p. 20). That announcement touched off a firestorm of controversy and debates among scientists about whether a self-imposed moratorium on heritable editing should be enacted. In December 2019, He was sentenced to three years in prison for forging documents to make it look as if he had approval from an ethics review board to do the work. The film’s only reference to the event is a title card at the end that briefly lays out what happened and states, “It marked the first time in history that humans edited the genetic code of a future generation. This controversial experiment has intensified the global debate about where we, as a species, should draw the line.”

He’s announcement came as filming for Human Nature was wrapping up. It was too late "to add anything substantive" that would capture all the nuances of the case, says the film’s director, Adam Bolt. The Chinese researcher’s medical ethics violations might also have detracted from the film’s exploration of whether to allow heritable editing in general, Bolt says. “We really wanted to make this film about the larger debate of ‘should we do this.’ ”

The film also glosses over some potential environmental impacts. The idea of bringing back extinct animals (complete with a clip from Jurassic Park) is discussed. But the concept of gene drives, which has more immediate implications, is overlooked. Scientists envision using gene drives — a self-replicating, cut-and-paste version of CRISPR — to eliminate malaria-carrying mosquitoes or remove invasive species, for example. But by introducing harmful genes into wild organisms, gene drives have the potential to send entire species to extinction (SN: 10/27/18, p. 6). Granted, gene drives are hard to explain, but they deserve a mention.

Overall, Human Nature gets the science right, but its explanation of how CRISPR works is incomplete and may be misleading. The film shows an application of CRISPR that involves cutting out DNA containing a mutation and then pasting in a healthy copy of the gene. CRISPR theoretically could work that way, but in practice scientists have had trouble with this method. Instead, when CRISPR makes a cut, the ends of the cut DNA strands usually are haphazardly glued back together, making a mutation that can break a gene. That may not sound useful, but it is the basis for some possible treatments for genetic diseases (SN: 8/31/19, p. 6).

Human Nature is a good introduction for those wondering what the fuss over CRISPR is about. No film can capture the full breadth of the tool’s reach. But by avoiding CRISPR babies, gene drives or even some of the challenges of treating diseases, the film paints a rosier picture than is warranted. Those topics deserve a sequel.

Ubigene Biosciences is co-founded by biological academics and elites from China, the United States, and France. We are located in Guangzhou Science City, which serves as a global center for high technology and innovation. Ubigene Biosciences has 1000㎡ office areas and laboratories, involving genome editing, cell biology technology, and zebrafish research. We provide products and services for plasmids, viruses, cells, and zebrafish. We aim to provide customers with better gene-editing tools for cell or animal research.

We developed CRISPR-U™ and CRISPR-B™(based on CRISPR/Cas9 technology) which is more efficient than general CRISPR/Cas9 in double-strand breaking, CRISPR-U™ and CRISPR-B™ can greatly improve the efficiency of homologous recombination, easily achieve knockout (KO), point mutation (PM) and knockin (KI) in vitro and in vivo. 

Genome Editing Platform
——Focusing on the Application of CRISPR-U™ and CRISPR-B™ Gene Editing Technology
1. Provides various types of gene-editing vectors for different species.
2. Provides different virus packaging services, including lentiviruses, adenoviruses and adeno-associated viruses.3. Provides high-quality services for gene knockout, point mutation and knockin cell lines

Cell Biology Platform
——Focusing on primary cell
1. Provides over 400 types of primary cells.
2. Provides culture strategies and related products for different cell types.3. Provides cell biology-related services such as cell isolation, extraction and validation.

Contact us